Effects of SU-13437 on serum lipids in hyperlipoproteinemic patients.
D000328:Adult; D000368:Aged; D001219:Aspartate Aminotransferases / Q000097:blood; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000139:chemically induced; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000188:drug therapy*; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010919:Placebos; D011422:Propionates / Q000009:adverse effects / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood; D014839:Vomiting / Q000139:chemically induced
D008074:Lipoproteins; D010919:Placebos; D011422:Propionates; D014280:Triglycerides; D001219:Aspartate Aminotransferases